Zura Bio Updates Principal Executive Offices and Contact Info
Ticker: ZURA · Form: 8-K · Filed: Feb 2, 2024 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance
TL;DR
**Zura Bio changed its address and phone number, nothing major for investors.**
AI Summary
Zura Bio Ltd. filed an 8-K on February 2, 2024, to update its principal executive offices to 1489 W. Warm Springs Rd. #110, Henderson, NV 89014, and its telephone number to (702) 757-6133. This change in address and contact information is a routine administrative update and does not signal any immediate operational or financial shifts, meaning it's unlikely to directly impact the stock's value for current or prospective investors.
Why It Matters
This filing is a routine administrative update, informing the public of a change in Zura Bio's physical address and phone number. It does not indicate any strategic shifts or financial performance changes.
Risk Assessment
Risk Level: low — This filing is purely administrative and does not present any new financial or operational risks to the company or its investors.
Analyst Insight
A smart investor would recognize this as a non-material administrative update and would not base any investment decisions solely on this filing. It's important to monitor for more substantive operational or financial news.
Key Players & Entities
- Zura Bio Ltd. (company) — the registrant filing the 8-K
- 1489 W. Warm Springs Rd. #110, Henderson, NV 89014 (address) — new principal executive offices
- (702) 757-6133 (phone_number) — new registrant's telephone number
- February 2, 2024 (date) — date of earliest event reported
- 001-40598 (string) — Commission File Number
FAQ
What is the primary purpose of Zura Bio Ltd.'s 8-K filing dated February 2, 2024?
The primary purpose of Zura Bio Ltd.'s 8-K filing dated February 2, 2024, is to report a change in its principal executive offices and telephone number, as stated under 'Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' (though the filing only explicitly mentions the address and phone change, not personnel).
What is Zura Bio Ltd.'s new principal executive office address?
Zura Bio Ltd.'s new principal executive office address is 1489 W. Warm Springs Rd. #110, Henderson, NV 89014, as reported in the filing.
What is the new telephone number for Zura Bio Ltd.?
The new telephone number for Zura Bio Ltd. is (702) 757-6133, according to the 8-K filing.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 2, 2024, as indicated by 'Date of Report (Date of earliest event reported)'.
What is the trading symbol for Zura Bio Ltd.'s Class A Ordinary Shares?
The trading symbol for Zura Bio Ltd.'s Class A Ordinary Shares, par value $0.0001 per share, is ZURA, and it is registered on The Nasdaq exchange, as stated in the filing.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-02-02 06:02:07
Key Financial Figures
- $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
- $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma
Filing Documents
- tm244433d1_8k.htm (8-K) — 30KB
- tm244433d1_ex99-1.htm (EX-99.1) — 12KB
- tm244433d1_ex99-1img001.jpg (GRAPHIC) — 9KB
- 0001104659-24-009658.txt ( ) — 275KB
- zura-20240202.xsd (EX-101.SCH) — 3KB
- zura-20240202_def.xml (EX-101.DEF) — 26KB
- zura-20240202_lab.xml (EX-101.LAB) — 36KB
- zura-20240202_pre.xml (EX-101.PRE) — 25KB
- tm244433d1_8k_htm.xml (XML) — 5KB
01
Item 7.01. Regulation FD Disclosure. On February 2, 2024, Zura Bio Limited issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated February 2, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 2, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer